Pathway Capital Management, LP
- SEC CIK
- 0001037353
- Latest filing
- Aug 3, 2026
JNCE holding history
Jounce Therapeutics, Inc. in every 13F filed by Pathway Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JNCE overviewAll 13F holders of JNCEFull Q2 2026 holdings
- Shares (Q4 2021)
- 0
- Sold out in Q4 2021
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 2
- Since Q2 2021